FDA Inspection 1066772 — Morning Star OTC, Inc.

Morning Star OTC, Inc. — FEI 3008674424

The FDA completed an inspection of Morning Star OTC, Inc. on September 26, 2018 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
163321 CFR 211.130(d)Examination of packaging and labeling
434221 CFR 211.142(b)Storage under appropriate conditions